Zacks Investment Management Bristol Myers Squibb CO Transaction History

Zacks Investment Management

$11.4 Billion
Q3 2024

A detailed history of Zacks Investment Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zacks Investment Management holds 4,983 shares of BMY stock, worth $287,818. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,983

Previous 11,432 56.41%

Holding current value

$287,818

Previous $474,000 45.78%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $255,767 - $333,735	-6,449 Reduced 56.41%	4,983 $257,000
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $8.54 Million - $11.2 Million	-212,259 Reduced 94.89%	11,432 $474,000
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $9.93 Million - $11.3 Million	207,061 Added 1245.11%	223,691 $12.1 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $11.2 Million - $13.4 Million	-231,103 Reduced 93.29%	16,630 $853,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $50.3 Million - $56.3 Million	-869,640 Reduced 77.83%	247,733 $14.4 Million
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $5.09 Million - $5.66 Million	79,955 Added 7.71%	1,117,373 $71.5 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $4.38 Million - $4.86 Million	-68,722 Reduced 6.21%	1,037,418 $66.3 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $2.14 Million - $2.43 Million	32,632 Added 3.04%	1,106,140 $76.7 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $3.03 Million - $3.59 Million	44,215 Added 4.3%	1,073,508 $77.2 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2,373 - $1.4 Million	18,258 Added 1.81%	1,029,293 $73.2 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $4.31 Million - $4.75 Million	59,363 Added 6.24%	1,011,035 $77.9 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $6.8 Million - $8.16 Million	110,680 Added 13.16%	951,672 $69.5 Million
Q4 2021 Feb 15, 2022	SELL	$53.63 - $62.52 $2.91 Million - $3.39 Million	-54,293 Reduced 6.06%	840,992 $52.4 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $17.9 Million - $21 Million	303,000 Added 51.16%	895,285 $53 Million
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $1.8 Million - $1.96 Million	29,071 Added 5.16%	592,285 $39.6 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $2.27 Million - $2.56 Million	-38,309 Reduced 6.37%	563,214 $35.6 Million
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $1.06 Million - $1.2 Million	-18,281 Reduced 2.95%	601,523 $37.3 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $25.5 Million - $28.2 Million	443,592 Added 251.74%	619,804 $37.4 Million
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $57,067 - $66,717	1,041 Added 0.59%	176,212 $10.4 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $8.13 Million - $11.8 Million	175,171 New	175,171 $9.76 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $562,076 - $733,178	-11,422 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $21.6 Million - $25.7 Million	-505,834 Reduced 97.79%	11,422 $579,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $307,833 - $340,396	6,899 Added 1.35%	517,256 $23.5 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $1.63 Million - $1.95 Million	36,173 Added 7.63%	510,357 $24.3 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $1.84 Million - $2.39 Million	-37,780 Reduced 7.38%	474,184 $24.6 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $349,573 - $394,291	-6,334 Reduced 1.22%	511,964 $31.8 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $167,557 - $208,841	3,316 Added 0.64%	518,298 $28.7 Million
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $685,305 - $788,924	11,437 Added 2.27%	514,982 $32.6 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $564,395 - $615,335	9,416 Added 1.91%	503,545 $30.9 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $27.3 Million - $31.5 Million	494,129	494,129 $31.5 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Zacks Investment Management with notifications on news.

Account

Zacks Investment Management Bristol Myers Squibb CO Transaction History